Stéphane Krief

Title: Stéphane Krief: Innovator in Benzimidazole Derivatives

Introduction

Stéphane Krief is a notable inventor based in Rennes, France. He has made significant contributions to the field of medicinal chemistry, particularly through his work on benzimidazole derivatives. With a total of five patents to his name, Krief's innovations have the potential to impact therapeutic applications significantly.

Latest Patents

Stéphane Krief's latest patents focus on benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands. The first patent discusses novel benzimidazole enantiomeric derivatives, their process of preparation, and their therapeutic uses as dual H1 and H4 receptor ligands. The second patent reiterates the same focus, emphasizing the importance of these compounds in medicinal applications.

Career Highlights

Throughout his career, Krief has worked with prominent companies in the pharmaceutical sector, including Bioprojet and Bioprojet Pharma. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Stéphane Krief has collaborated with several professionals in his field, including Isabelle Berrebi-Bertrand and Xavier Billot. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Stéphane Krief is a distinguished inventor whose work on benzimidazole derivatives showcases his commitment to advancing medicinal chemistry. His contributions through patents and collaborations highlight his role in the ongoing development of innovative therapeutic solutions.